Millie
your market intelligence analyst
Search Results
199 results
Your search is now limited to «Company News in Infectious Diseases» expert search.
Reuters.com 05/26/2020 16:13
Merck did not disclose the terms of the acquisition of Themis, a privately held company.
More from Reuters.com:
Reuters.com 05/26/2020 11:15
Most big pharmaceutical companies have already placed their bets on COVID-19 treatments, but Merck has been waiting for opportunities with proven track records, Chief Executive Ken Frazier said.
More from Reuters.com:
Benzinga 05/26/2020 10:48
The company is partnering with IAVI, a nonprofit scientific research organization, to develop the vaccine using recombinant vesicular stomatitis virus technology, which is the basis for Merck's Ebola virus vaccine ERVEBO.
More from Benzinga:
STAT 05/26/2020 09:15
And the drug maker is partnering with IAVI, the nonprofit, to develop a Covid-19 vaccine related to an existing Merck Ebola vaccine that could enter human studies later this year.
More from STAT:
Forbes 05/26/2020 08:57
Photo by Arne Dedert/picture alliance via Getty Images KEY FACTS Merck and IAVI’s potential coronavirus vaccine will use the same technology that is in Merck’s Ebola Zaire virus vaccine, known as recombinant vesicular stomatitis virus (rVSV.
More from Forbes:
GlobeNewswire 05/26/2020 07:30
YONKERS, N.Y., May 26, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: CFRX), a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the treatment of life-threatening infectious diseases, today announced that Pfizer Inc. (NYSE: PFE) has entered into a stock purchase agreement with ContraFect pursuant to which Pfizer Inc. has agreed to purchase 674,156 shares of ContraFect’s common stock and a warrant to purchase 505,617 shares of ContraFect’s common stock, for approximately $3.0 million in a private placement transaction that is expected to close on May 27, 2020.
More from GlobeNewswire:
CNBC - Business 05/26/2020 07:27
The plan, they continued, was to "leverage experience" gained with this platform during the development of Merck's rVSV-based vaccine for Ebola Zaire.
More from CNBC - Business:
MarketWatch 05/26/2020 07:24
Merck’s second coronavirus vaccine effort will take the form of a partnership with the scientific-research organization IAVI, whose experimental vaccine uses the same technology that is the basis for Merck’s Ebola Zaire virus vaccine, Dr. Perlmutter said ...
More from MarketWatch:
Business Wire 05/26/2020 06:51
This agreement with Merck, a leader in infectious disease therapeutics, positions us to harness the full potential of EIDD-2801 and, if approved, deliver it to the patients that need it globally.
More from Business Wire:
Taipei Times (Taiwan) 05/21/2020 12:34
AstraZeneca PLC said it has received more than US$1 billion in US government funding to develop a COVID-19 vaccine with Oxford University, adding that it has supply agreements for 400 million doses.
More from Taipei Times (Taiwan):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications